Dapsone
Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer CenterSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
METRONIDAZOLE Memorial Sloan Kettering Cancer Center | Phase 3 | BB |
Topical Dapsone 5% Gel Memorial Sloan Kettering Cancer Center | Phase 3 | BB |
NEOMYCIN Memorial Sloan Kettering Cancer Center | Phase 3 | BB |
Same molecule, other indications
Dapsone is also rated in:
Cetuximab-induced Papulopustular (Acneiform) Rash Who HaveDormant
BB
Indicative ·
64 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →